The Journal of Immunology, Vol 156, Issue 11 4484-4491, Copyright © 1996 by American Association of Immunologists

ARTICLES

Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen

ST Cheng, TQ Nguyen, YS Yang, JD Capra and RD Sontheimer
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.

Calreticulin (CR) is a multifunctional, calcium-binding protein that has recently been shown to bind to and promote the replication of the rubella virus genome in mammalian cells. While CR is now widely recognized as a new human autoantigen, the relationship between CR and the Ro/SS-A ribonucleo-protein (RNP) autoantigen has been somewhat controversial. In this work, we demonstrate that unphosphorylated human rCR binds specifically and distinctly to in vitro transcribed forms of hYRNA, the RNA backbone of the Ro/SS-A RNP particle. This interaction appears to be mediated by binding through the N- and C-terminal domains of CR, but not by the central proline-rich domain. Furthermore, our studies indicate that CR can facilitate the binding of the 60-kDa polypeptide component of the Ro/SS-A RNP (Ro60) to hYRNA. In addition, CR and the 52-kDa Ro/SS-A polypeptide (Ro52) appear to be capable of interacting through direct protein-protein binding. These studies confirm that CR is an hYRNA-binding protein, and provide for the first time a molecular mechanism by which Ro52 can be linked physically to hYRNA. Through these molecular interactions and its known functional role as a chaperone, it is suggested that CR plays a supportive role in the formation of the Ro/SS-A RNP complex. The capacity of CR to interact with RNA viruses such as rubella provides an additional argument for an infectious trigger for autoantibody production against self RNP particles such as Ro/SS-A.

This article has been cited by other articles:

				M. B. Decca, M. A. Carpio, C. Bosc, M. R. Galiano, D. Job, A. Andrieux, and M. E. Hallak Post-translational Arginylation of Calreticulin: A NEW ISOSPECIES OF CALRETICULIN COMPONENT OF STRESS GRANULES J. Biol. Chem., March 16, 2007; 282(11): 8237 - 8245. [Abstract] [Full Text] [PDF]

				D I Mitsias, E K Kapsogeorgou, and H M Moutsopoulos The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren's syndrome (autoimmune epithelitis) Lupus, May 1, 2006; 15(5): 255 - 261. [Abstract] [PDF]

				L. T. Timchenko, P. Iakova, A. L. Welm, Z.-J. Cai, and N. A. Timchenko Calreticulin Interacts with C/EBP{alpha} and C/EBP{beta} mRNAs and Represses Translation of C/EBP Proteins Mol. Cell. Biol., October 15, 2002; 22(20): 7242 - 7257. [Abstract] [Full Text] [PDF]

				N. Seddiki, F. Nato, P. Lafaye, Z. Amoura, J. C. Piette, and J. C. Mazie Calreticulin, a Potential Cell Surface Receptor Involved in Cell Penetration of Anti-DNA Antibodies J. Immunol., May 15, 2001; 166(10): 6423 - 6429. [Abstract] [Full Text] [PDF]

				J. M. Holaska, B. E. Black, D. C. Love, J. A. Hanover, J. Leszyk, and B. M. Paschal Calreticulin Is a Receptor for Nuclear Export J. Cell Biol., January 8, 2001; 152(1): 127 - 140. [Abstract] [Full Text] [PDF]

				D M Racila and R D Sontheimer C1q inhibits autoantibody binding to calreticulin Lupus, May 1, 1999; 8(4): 300 - 304. [Abstract] [PDF]

				M.-H. Chen and T. K. Frey Mutagenic Analysis of the 3' cis-Acting Elements of the Rubella Virus Genome J. Virol., April 1, 1999; 73(4): 3386 - 3403. [Abstract] [Full Text]

				S Treves, G Bajocchi, F Zorzato, M Govoni, and F Trotta Identification and characterization of a calreticulin-binding nuclear protein as histone (H1), an autoantigen in systemic lupus erythematosus Lupus, September 1, 1998; 7(7): 479 - 487. [Abstract] [PDF]

				G Kinoshita, C L Keech, R D Sontheimer, A Purcell, J McCluskey, and T P Gordon Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity Lupus, January 1, 1998; 7(1): 7 - 11. [Abstract] [PDF]

				G. M. Denning, K. G. Leidal, V. A. Holst, S. S. Iyer, D. W. Pearson, J. R. Clark, W. M. Nauseef, and R. A. Clark Calreticulin Biosynthesis and Processing in Human Myeloid Cells: Demonstration of Signal Peptide Cleavage and N-Glycosylation Blood, July 1, 1997; 90(1): 372 - 381. [Abstract] [Full Text] [PDF]

				L. Lee and W. Weston Cutaneous lupus erythematosus during the neonatal and childhood periods Lupus, January 1, 1997; 6(2): 132 - 138. [Abstract] [PDF]

				P. Eggleton, K. Reid, U. Kishore, and R. Sontheimer Review : Clinical relevance of calreticulin in systemic lupus erythematosus Lupus, January 1, 1997; 6(7): 564 - 571. [Abstract] [PDF]

				G. Fabini, R. Raijmakers, S. Hayer, M. A. Fouraux, G. J. M. Pruijn, and G. Steiner The Heterogeneous Nuclear Ribonucleoproteins I and K Interact with a Subset of the Ro Ribonucleoprotein-associated Y RNAs in Vitro and in Vivo J. Biol. Chem., June 1, 2001; 276(23): 20711 - 20718. [Abstract] [Full Text] [PDF]